Basel Medical Group Ltd
BMGL
Last
$3.68
Day
+2.2%
1y
-81.7%
5y
-93.2%
52w
-83.4%
SPY YTD
+13.3%
XLV
+8.1%
Earnings
—
EMA 21
3.86
EMA 50
4.65
EMA 200
9.08
20d high
-61.0%
5y high
-96.8%
5y range
1th
Positions held
Your positionsBMGL isn't in your positions.
Add it to see shares, cost, and P&L here.
Score
-6
Hold
avoid
Signal
Sell
Target
$4.41
Stop
$2.93
Stop distance
20.4%
Target vs last
+19.8%
Fundamentals
| Market cap | $5.70M | Enterprise value | $7.30M | Trailing P/E | — | Forward P/E | — |
| PEG | — | Price / book | 1.15 | Beta | — | Dividend yield | 0.00% |
| Revenue growth | 67.1% | Earnings growth | — | Gross margin | 14.0% | Operating margin | -32.8% |
| Profit margin | -68.2% | ROE | -147.4% | ROA | -15.5% | Debt / equity | 1.51 |
| Current ratio | 1.89 | Free cash flow | -$11.75M | Analyst recommendation | none | Mean target | — |
| 52w high | $21.72 | 52w low | $2.56 |
Quarterly
No data yet.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $11.3M | $10.1M | $9.7M | $10.7M |
| Op margin | -19.2% | 21.8% | 21.4% | 23.2% |
| Net income | -$10.6M | $2.1M | $1.8M | $2.0M |
| Gross margin | 77.5% | 77.6% | 75.9% | 79.6% |
| Gross profit | $8.8M | $7.8M | $7.4M | $8.5M |
| Operating income | -$2.2M | $2.2M | $2.1M | $2.5M |
Headline scan
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
Price (daily)
Full chart · RSI · MACD · patternsBMGL · daily-21.6% over 14 sessions
Close EMA21 EMA50 EMA200